Development of transformative therapies for the treatment of whorsening and accute decompensated heart failure
Location: France, Ile-of-France, Paris
Employees: 1-10
Total raised: $69.596873M
Founded date: 2021
Investors 4
Date | Name | Website |
01.11.2023 | Jeito Capi... | jeito.life |
27.11.2023 | V-Bio Vent... | v-bio.vent... |
30.10.2023 | Kurma Part... | kurmapartn... |
25.10.2023 | OrbiMed | orbimed.co... |
Funding Rounds 1
Date | Series | Amount | Investors |
08.09.2023 | Series A | $69.596873... | - |
Mentions in press and media 4
Date | Title | Description | Source |
08.09.2023 | France-based Corteria Pharmaceuticals raises EUR 65 million ... | Paris, France-based biopharmaceutical company specialized in the development of transformative thera... | vcbay.news... |
07.09.2023 | Corteria Pharmaceuticals Announces a €65M Financing to Adv... | Corteria Pharmaceuticals (“Corteria”), a biopharmaceutical company specialized in the development of... | fh-partner... |
07.09.2023 | Corteria Pharmaceuticals Raises €65M in Series A Funding | Corteria Pharmaceuticals, a Paris, France-based biopharmaceutical company specialized in the develop... | finsmes.co... |
21.10.2022 | Corteria Pharmaceuticals strengthens its Executive Leaders... | Corteria Pharmaceuticals, a biotechnology company developing innovative treatments for certain forms... | fh-partner... |